Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2005 Jul;90(4):F301–F306. doi: 10.1136/adc.2004.065250

Erythromycin as a prokinetic agent in preterm neonates: a systematic review

S Patole, S Rao, D Doherty
PMCID: PMC1721900  PMID: 15899929

Abstract

Background: It often takes several days or even weeks to establish full enteral feeds (FEFs) in preterm, especially extremely low birthweight neonates because of feed intolerance related to gastrointestinal hypomotility. Clinical trials of erythromycin as a prokinetic agent in preterm neonates have reported conflicting results.

Aim: To systematically review the efficacy and safety of erythromycin as a prokinetic agent in preterm neonates.

Methods: Only randomised controlled trials in preterm neonates (gestation ⩽37 weeks) were considered eligible for inclusion. The primary outcome was the time to reach FEFs of 150 ml/kg/day. The secondary outcomes included the incidence of erythromycin related adverse effects such as diarrhoea, cardiac arrhythmias, and hypertrophic pyloric stenosis. No restrictions were applied on the dose (low: 3–12 mg/kg/day; antimicrobial: ⩾12 mg/kg/6–8 hours) and route (oral or intravenous) and mode (prophylactic or rescue) of administration. The standard methodology for systematic reviews was followed. A subgroup analysis was preplanned based on the dose and mode of drug administration.

Results: Seven trials (three prophylaxis, four rescue) with various doses, routes and modes of administration, and durations of erythromycin treatment and different results were found to be eligible for inclusion in the analysis. Meta-analysis could not be performed, as specific data were either inadequate or not available.

Conclusion: The conflicting trial results may be explained by differences in dose and route and mode of administration of erythromycin and in gastrointestinal motor responses in the presence of different feeding conditions—for example, fasting v fed state, intermittent v continuous feeds. Gestational and postnatal ages during erythromycin treatment are also important.

Full Text

The Full Text of this article is available as a PDF (83.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annese V., Janssens J., Vantrappen G., Tack J., Peeters T. L., Willemse P., Van Cutsem E. Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination. Gastroenterology. 1992 Mar;102(3):823–828. doi: 10.1016/0016-5085(92)90164-t. [DOI] [PubMed] [Google Scholar]
  2. Bell M. J., Ternberg J. L., Feigin R. D., Keating J. P., Marshall R., Barton L., Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978 Jan;187(1):1–7. doi: 10.1097/00000658-197801000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berseth C. L. Gestational evolution of small intestine motility in preterm and term infants. J Pediatr. 1989 Oct;115(4):646–651. doi: 10.1016/s0022-3476(89)80302-6. [DOI] [PubMed] [Google Scholar]
  4. Bryant M. G., Buchan A. M., Gregor M., Ghatei M. A., Polak J. M., Bloom S. R. Development of intestinal regulatory peptides in the human fetus. Gastroenterology. 1982 Jul;83(1 Pt 1):47–54. [PubMed] [Google Scholar]
  5. Cavell B. Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand. 1981 Sep;70(5):639–641. [PubMed] [Google Scholar]
  6. Clark Reese H., Thomas Pam, Peabody Joyce. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics. 2003 May;111(5 Pt 1):986–990. doi: 10.1542/peds.111.5.986. [DOI] [PubMed] [Google Scholar]
  7. Code C. F., Marlett J. A. The interdigestive myo-electric complex of the stomach and small bowel of dogs. J Physiol. 1975 Mar;246(2):289–309. doi: 10.1113/jphysiol.1975.sp010891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cooke R. J., Ainsworth S. B., Fenton A. C. Postnatal growth retardation: a universal problem in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2004 Sep;89(5):F428–F430. doi: 10.1136/adc.2001.004044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooper William O., Griffin Marie R., Arbogast Patrick, Hickson Gerald B., Gautam Shiva, Ray Wayne A. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med. 2002 Jul;156(7):647–650. doi: 10.1001/archpedi.156.7.647. [DOI] [PubMed] [Google Scholar]
  10. Coulie B., Tack J., Peeters T., Janssens J. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut. 1998 Sep;43(3):395–400. doi: 10.1136/gut.43.3.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cucchiara S., Minella R., Scoppa A., Emiliano M., Calabrese F., Az-Zeqeh N., Rea B., Salvia G. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. J Pediatr Gastroenterol Nutr. 1997 Apr;24(4):411–418. doi: 10.1097/00005176-199704000-00010. [DOI] [PubMed] [Google Scholar]
  12. Donnell S. C., Taylor N., van Saene H. K. F., Magnall V. L., Pierro A., Lloyd D. A. Infection rates in surgical neonates and infants receiving parenteral nutrition: a five-year prospective study. J Hosp Infect. 2002 Dec;52(4):273–280. doi: 10.1053/jhin.2002.1318. [DOI] [PubMed] [Google Scholar]
  13. Ehrenkranz R. A., Younes N., Lemons J. A., Fanaroff A. A., Donovan E. F., Wright L. L., Katsikiotis V., Tyson J. E., Oh W., Shankaran S. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics. 1999 Aug;104(2 Pt 1):280–289. doi: 10.1542/peds.104.2.280. [DOI] [PubMed] [Google Scholar]
  14. ElHennawy Adel A., Sparks John W., Armentrout Debra, Huseby Valerie, Berseth Carol Lynn. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):281–286. doi: 10.1097/00005176-200309000-00015. [DOI] [PubMed] [Google Scholar]
  15. Embleton N. E., Pang N., Cooke R. J. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics. 2001 Feb;107(2):270–273. doi: 10.1542/peds.107.2.270. [DOI] [PubMed] [Google Scholar]
  16. Farrar H. C., Walsh-Sukys M. C., Kyllonen K., Blumer J. L. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature. Pediatr Infect Dis J. 1993 Aug;12(8):688–691. doi: 10.1097/00006454-199308000-00011. [DOI] [PubMed] [Google Scholar]
  17. Gouyon J. B., Benoit A., Bétremieux P., Sandre D., Sgro C., Bavoux F., Beneton C., Badoual J. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants. Pediatr Infect Dis J. 1994 Sep;13(9):840–841. doi: 10.1097/00006454-199409000-00028. [DOI] [PubMed] [Google Scholar]
  18. Gouyon J. B. The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children. J Pediatr Gastroenterol Nutr. 1992 Jan;14(1):120–120. doi: 10.1097/00005176-199201000-00029. [DOI] [PubMed] [Google Scholar]
  19. Hauben Manfred, Amsden Guy W. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Drug Saf. 2002;25(13):929–942. doi: 10.2165/00002018-200225130-00004. [DOI] [PubMed] [Google Scholar]
  20. Itoh Z., Nakaya M., Suzuki T., Arai H., Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol. 1984 Dec;247(6 Pt 1):G688–G694. doi: 10.1152/ajpgi.1984.247.6.G688. [DOI] [PubMed] [Google Scholar]
  21. Itoh Z., Suzuki T., Nakaya M., Inoue M., Arai H., Wakabayashi K. Structure-activity relation among macrolide antibiotics in initiation of interdigestive migrating contractions in the canine gastrointestinal tract. Am J Physiol. 1985 Mar;248(3 Pt 1):G320–G325. doi: 10.1152/ajpgi.1985.248.3.G320. [DOI] [PubMed] [Google Scholar]
  22. Itoh Z., Suzuki T., Nakaya M., Inoue M., Mitsuhashi S. Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut. Antimicrob Agents Chemother. 1984 Dec;26(6):863–869. doi: 10.1128/aac.26.6.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ittmann P. I., Amarnath R., Berseth C. L. Maturation of antroduodenal motor activity in preterm and term infants. Dig Dis Sci. 1992 Jan;37(1):14–19. doi: 10.1007/BF01308336. [DOI] [PubMed] [Google Scholar]
  24. Jadcherla S. R., Klee G., Berseth C. L. Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res. 1997 Sep;42(3):365–369. doi: 10.1203/00006450-199709000-00018. [DOI] [PubMed] [Google Scholar]
  25. Jadcherla Sudarshan R., Kliegman Robert M. Studies of feeding intolerance in very low birth weight infants: definition and significance. Pediatrics. 2002 Mar;109(3):516–517. doi: 10.1542/peds.109.3.516. [DOI] [PubMed] [Google Scholar]
  26. Jadcherla Sudarshan Rao, Berseth Carol Lynn. Effect of erythromycin on gastroduodenal contractile activity in developing neonates. J Pediatr Gastroenterol Nutr. 2002 Jan;34(1):16–22. doi: 10.1097/00005176-200201000-00005. [DOI] [PubMed] [Google Scholar]
  27. Janssens J., Peeters T. L., Vantrappen G., Tack J., Urbain J. L., De Roo M., Muls E., Bouillon R. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990 Apr 12;322(15):1028–1031. doi: 10.1056/NEJM199004123221502. [DOI] [PubMed] [Google Scholar]
  28. Kaufman Stuart S., Gondolesi Gabriel E., Fishbein Thomas M. Parenteral nutrition associated liver disease. Semin Neonatol. 2003 Oct;8(5):375–381. doi: 10.1016/S1084-2756(03)00094-0. [DOI] [PubMed] [Google Scholar]
  29. Kubota M., Nakamura T., Motokura T., Mori S., Nishida A. Erythromycin improves gastrointestinal motility in extremely low birthweight infants. Acta Paediatr Jpn. 1994 Apr;36(2):198–201. doi: 10.1111/j.1442-200x.1994.tb03161.x. [DOI] [PubMed] [Google Scholar]
  30. Mahon B. E., Rosenman M. B., Kleiman M. B. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr. 2001 Sep;139(3):380–384. doi: 10.1067/mpd.2001.117577. [DOI] [PubMed] [Google Scholar]
  31. Ng E., Shah V. Erythromycin for feeding intolerance in preterm infants. Cochrane Database Syst Rev. 2001;(2):CD001815–CD001815. doi: 10.1002/14651858.CD001815. [DOI] [PubMed] [Google Scholar]
  32. Ng P. C., Fok T. F., Lee C. H., Wong W., Cheung K. L. Erythromycin treatment for gastrointestinal dysmotility in preterm infants. J Paediatr Child Health. 1997 Apr;33(2):148–150. doi: 10.1111/j.1440-1754.1997.tb01018.x. [DOI] [PubMed] [Google Scholar]
  33. Ng P. C., So K. W., Fung K. S., Lee C. H., Fok T. F., Wong E., Wong W., Cheung K. L., Cheng A. F. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2001 May;84(3):F177–F182. doi: 10.1136/fn.84.3.F177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ng Steven Chin-Yuen, Gomez Joseph Manuel, Rajadurai Victor Samuel, Saw Seang-Mei, Quak Seng-Hock. Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin. J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):554–558. doi: 10.1097/00005176-200311000-00009. [DOI] [PubMed] [Google Scholar]
  35. Oei J., Lui K. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants. Acta Paediatr. 2001 Aug;90(8):904–908. [PubMed] [Google Scholar]
  36. Otterson M. F., Sarna S. K. Gastrointestinal motor effects of erythromycin. Am J Physiol. 1990 Sep;259(3 Pt 1):G355–G363. doi: 10.1152/ajpgi.1990.259.3.G355. [DOI] [PubMed] [Google Scholar]
  37. Parkman H. P., Pagano A. P., Vozzelli M. A., Ryan J. P. Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach. Am J Physiol. 1995 Sep;269(3 Pt 1):G418–G426. doi: 10.1152/ajpgi.1995.269.3.G418. [DOI] [PubMed] [Google Scholar]
  38. Patole S. K., Almonte R., Kadalraja R., Tuladhar R., Muller R., Whitehall J. S. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? Int J Clin Pract. 2000 Oct;54(8):504–508. [PubMed] [Google Scholar]
  39. Patole S., Muller R. Enteral feeding of preterm neonates: a survey of Australian neonatologists. J Matern Fetal Neonatal Med. 2004 Nov;16(5):309–314. doi: 10.1080/14767050400017983. [DOI] [PubMed] [Google Scholar]
  40. Peeters T. L. Erythromycin and other macrolides as prokinetic agents. Gastroenterology. 1993 Dec;105(6):1886–1899. doi: 10.1016/0016-5085(93)91089-z. [DOI] [PubMed] [Google Scholar]
  41. Peeters T., Matthijs G., Depoortere I., Cachet T., Hoogmartens J., Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol. 1989 Sep;257(3 Pt 1):G470–G474. doi: 10.1152/ajpgi.1989.257.3.G470. [DOI] [PubMed] [Google Scholar]
  42. Pennathur A., Tran A., Cioppi M., Fayad J., Sieren G. L., Little A. G. Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease. Am J Surg. 1994 Jan;167(1):169–173. doi: 10.1016/0002-9610(94)90069-8. [DOI] [PubMed] [Google Scholar]
  43. Qin X. Y., Pilot M. A., Thompson H., Scott M. Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis. Br J Pharmacol. 1993 Jan;108(1):44–49. doi: 10.1111/j.1476-5381.1993.tb13437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Radmacher Paula G., Looney Stephen W., Rafail Salisa T., Adamkin David H. Prediction of extrauterine growth retardation (EUGR) in VVLBW infants. J Perinatol. 2003 Jul-Aug;23(5):392–395. doi: 10.1038/sj.jp.7210947. [DOI] [PubMed] [Google Scholar]
  45. Simkiss D. E., Adams I. P., Myrdal U., Booth I. W. Erythromycin in neonatal postoperative intestinal dysmotility. Arch Dis Child. 1994 Sep;71(2):F128–F129. doi: 10.1136/fn.71.2.f128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Stenson B. J., Middlemist L., Lyon A. J. Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 1998 Nov;79(3):F212–F214. doi: 10.1136/fn.79.3.f212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Steward Deborah K., Pridham Karen F. Growth patterns of extremely low-birth-weight hospitalized preterm infants. J Obstet Gynecol Neonatal Nurs. 2002 Jan-Feb;31(1):57–65. doi: 10.1111/j.1552-6909.2002.tb00023.x. [DOI] [PubMed] [Google Scholar]
  48. Su B. H., Lin H. C., Peng C. T., Tsai C. H. Effect of erythromycin on feeding intolerance in very low birth weight infants: a preliminary observation. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1998 Sep-Oct;39(5):324–326. [PubMed] [Google Scholar]
  49. Sweet Matthew P., Hodgman Joan E., Pena Ivette, Barton Lorayne, Pavlova Zdena, Ramanathan Rangasamy. Two-year outcome of infants weighing 600 grams or less at birth and born 1994 through 1998. Obstet Gynecol. 2003 Jan;101(1):18–23. doi: 10.1016/s0029-7844(02)02451-1. [DOI] [PubMed] [Google Scholar]
  50. Sørensen Henrik Toft, Skriver Mette Vinther, Pedersen Lars, Larsen Helle, Ebbesen Finn, Schønheyder Henrik C. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis. 2003;35(2):104–106. doi: 10.1080/0036554021000027010. [DOI] [PubMed] [Google Scholar]
  51. Tack J., Janssens J., Vantrappen G., Peeters T., Annese V., Depoortere I., Muls E., Bouillon R. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology. 1992 Jul;103(1):72–79. doi: 10.1016/0016-5085(92)91097-n. [DOI] [PubMed] [Google Scholar]
  52. Tomomasa T., Hyman P. E., Itoh K., Hsu J. Y., Koizumi T., Itoh Z., Kuroume T. Gastroduodenal motility in neonates: response to human milk compared with cow's milk formula. Pediatrics. 1987 Sep;80(3):434–438. [PubMed] [Google Scholar]
  53. Tomomasa T., Kuroume T., Arai H., Wakabayashi K., Itoh Z. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci. 1986 Feb;31(2):157–161. doi: 10.1007/BF01300701. [DOI] [PubMed] [Google Scholar]
  54. Tomomasa T., Miyazaki M., Koizumi T., Kuroume T. Erythromycin increases gastric antral motility in human premature infants. Biol Neonate. 1993;63(6):349–352. doi: 10.1159/000243954. [DOI] [PubMed] [Google Scholar]
  55. Urbain J. L., Vantrappen G., Janssens J., Van Cutsem E., Peeters T., De Roo M. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med. 1990 Sep;31(9):1490–1493. [PubMed] [Google Scholar]
  56. Vantrappen G., Janssens J., Hellemans J., Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977 Jun;59(6):1158–1166. doi: 10.1172/JCI108740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Walsh M. C., Kliegman R. M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986 Feb;33(1):179–201. doi: 10.1016/S0031-3955(16)34975-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. de Ville K., Knapp E., Al-Tawil Y., Berseth C. L. Slow infusion feedings enhance duodenal motor responses and gastric emptying in preterm infants. Am J Clin Nutr. 1998 Jul;68(1):103–108. doi: 10.1093/ajcn/68.1.103. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES